These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4983411)

  • 1. Current concepts of cutaneous porphyria and its treatment with particular reference to the use of sodium calciumedetate.
    Donald GF; Hunter GA; Roman W; Taylor AE
    Br J Dermatol; 1970 Jan; 82(1):70-5. PubMed ID: 4983411
    [No Abstract]   [Full Text] [Related]  

  • 2. [Porphyrias].
    Beritić T; Prpić-Majić D
    Lijec Vjesn; 1969; 91(2):203-9. PubMed ID: 4896913
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute intermittent porphyria.
    McEwin R
    Aust N Z J Surg; 1973 May; 42(4):327-31. PubMed ID: 4532511
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous porphyria. Favourable results in twelve cases treated by chelation.
    Donald GF; Hunter GA; Roman W; Taylor AE
    Aust J Dermatol; 1965 Dec; 8(2):97-115. PubMed ID: 4957272
    [No Abstract]   [Full Text] [Related]  

  • 5. [Porphyria and pregnancy].
    Huber FB
    Schweiz Med Wochenschr; 1966 Jun; 96(25):818-24. PubMed ID: 5987047
    [No Abstract]   [Full Text] [Related]  

  • 6. [Surgical aspects of acute intermittent porphyria].
    Soyka D
    Chirurg; 1966 Jul; 37(7):289-92. PubMed ID: 5992235
    [No Abstract]   [Full Text] [Related]  

  • 7. The acute porphyria attack. 3. Acute porphyria: the precipitating and aggravating factors.
    Eales L
    S Afr Med J; 1971 Sep; ():120-5. PubMed ID: 5150264
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of chloroquine therapy in seven cases of porphyria cutanea tarda: influence on clinical and chemical-clinical pictures (author's transl)].
    Arbosti G; Nava C; Ghezzi I; Grisler R; Brambilla G
    Med Lav; 1979; 70(3):239-47. PubMed ID: 470825
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of chloroquine therapy on the level of porphyrins in the liver in symptomatic hepatic porphyria].
    Martásek P; Jirsa M; Kordac V
    Cesk Gastroenterol Vyz; 1982 Jun; 36(3-4):198-205. PubMed ID: 7105200
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute intermittent porphyria: effect of diet and griseofulvin.
    Felsher BF; Redeker AG
    Medicine (Baltimore); 1967 Mar; 46(2):217-23. PubMed ID: 6027463
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of porphyria cutanea tarda by iron chelators (EDTA, Desferral)].
    Thivolet J; Bondet P; Perrot H; Moene Y
    Lyon Med; 1967 Aug; 218(32):225-30. PubMed ID: 4975716
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of adenosine-5-monophosphoric acid or inosine on porphyria caused by griseofulvin in rats.
    Gajdos A; Gajdos-Török M
    Nature; 1965 Apr; 206(981):297-8. PubMed ID: 5836322
    [No Abstract]   [Full Text] [Related]  

  • 13. Drugs and the hepatic porphyrias.
    Smith AG; De Matteis F
    Clin Haematol; 1980 Jun; 9(2):399-425. PubMed ID: 7398153
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of acute intermittent porphyria treated successfully with zinc sulpate and chelation.
    Roman W; Oon R; West RF; Reid DP
    Med J Aust; 1969 Mar; 1(12):633-8. PubMed ID: 4976611
    [No Abstract]   [Full Text] [Related]  

  • 15. The treatment of cutaneous porphyria with chloroquine or D-penicillamine.
    Hunter GA; Donald GF
    Br J Dermatol; 1970 Dec; 83(6):702-3. PubMed ID: 5492482
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on low dose chloroquine therapy and the action of chloroquine in symptomatic porphyria.
    Taljaard JJ; Shanley BC; Stewart-Wynne EG; Deppe WM; Joubert SM
    Br J Dermatol; 1972 Sep; 87(3):261-9. PubMed ID: 5080345
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical and biological effects of chelating agents in porphyria cutanea tarda].
    Thivolet J; Perrot H; Mallein R; Sabater P
    Presse Med (1893); 1968 Feb; 76(8):367-70. PubMed ID: 4967022
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic efficacy of oral charcoal in congenital erythropoietic porphyria.
    Pimstone NR; Gandhi SN; Mukerji SK
    N Engl J Med; 1987 Feb; 316(7):390-3. PubMed ID: 3100953
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of late cutaneous porphyrias with iron chelating agents (EDTA, Desferral)].
    Thivolet J; Bondet P; Perrot H; Moene Y
    Bull Soc Fr Dermatol Syphiligr; 1967; 74(3):388-91. PubMed ID: 4965024
    [No Abstract]   [Full Text] [Related]  

  • 20. [Porphyria cutanea tarda (chronic hepatic porphyria): new aspects on pathogenesis, diagnosis and therapy with a review of the workshop, "Cutaneous porphyrias" at the 17th World Congress of Dermatology in Berlin 1987].
    Doss MO
    Z Hautkr; 1988 Apr; 63(4):282-9. PubMed ID: 3291437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.